New Orleans Bio Showcased on International Scale
The New Orleans Business Alliance recently brought the Bayou to BIO!
Our goal was to spread the message that New Orleans is open for business by showcasing our local talent, infrastructure, research capabilities, culture, and incentives.
The 2019 BIO International Convention brought together over 15,000 representatives and leaders from top biotechnology companies, academic institutions, state biotechnology centers and related organizations to gather, partner, and learn. With the incredible developments taking place in our community, the New Orleans Business Alliance made our mark on the conference in Philadelphia.
Showcasing New Orleans
We were pleased to host an event with several partners included: Tulane University, LSU Health, Louisiana Economic Development, GNO Inc., and New Orleans & Company to host the most spirited reception of the week, “BIO from the BAYOU.”
More than 150 guests attended to network with our business community and learn about opportunities in New Orleans.
The New Orleans community presented a united front when taking advantage of partner meetings at the conference. LSU Health, Tulane, and the Business Alliance hosted 125 meetings over the four days, generating potential leads for research and business development purposes.
Additionally, the New Orleans Business Alliance team engaged dozens of companies and over 20 international economic development organizations at the Exhibit Hall, sharing key information about the thriving business landscape in New Orleans.
New Orleans-Based AxoSim Makes Announcement
One exciting highlight came from local biotech company, AxoSim. Already making waves with its nerve-on-a-chip technology, AxoSim announced the exclusive licensing of Johns Hopkins University’s “Mini-Brain” technology. Mini-Brain technology enables scientists to study key brain functions, test new therapies and screen for toxic substances in human rather than animal models at an early stage of research.
Combined with AxoSim’s Nerve-on-a-Chip technology, this “Mini-Brain” technology can speed the clinical testing and R&D of new neuro drugs and treatments.
Dr. Lowry Curley, CEO of AxoSim, announced the licensing at a panel he hosted, “Humans-in-a-Dish: Hope or Hype?”
Building a Reputation for Bio Innovation
By joining forces with local universities, economic development organizations, and high-growth biotech companies, Bio on the Bayou was a strong demonstration of New Orleans’ increasing prominence in bio and digital health technologies.
With leads generated from the BIO International Convention, the New Orleans Business Alliance, with partners LSU Health and Tulane, plan to turn relationships and leads into business and family-sustaining job growth for New Orleans.
